COREFORT
DEAD

Serial Number

79338958

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

COREFORT Trademark

Serial Number: 79338958 • Registration: 7033273

COREFORT is a trademark filed by NOVARTIS AG on March 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 10, 2022

Registration Date

April 25, 2023

Published for Opposition

February 7, 2023

Cancellation Date

September 8, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Drug delivery systems comprising infusion devices, injection devices, inhalers, polymer coatings, and bioadhesive polymers for the deferred, controlled or immediate release of active substances of pharmaceutical preparations

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 7, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 7, 2025 DETH
NOTIFICATION PROCESSED BY IB
Oct 23, 2023 GPNX
IRREGULARITY FROM IB EXAMINED BY MPU
Oct 2, 2023 IRRH
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Sep 18, 2023 IRFI
FINAL DISPOSITION NOTICE SENT TO IB
Aug 4, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 4, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 25, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 25, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 18, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 18, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 3, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 3, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 3, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 3, 2023 CNEA
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jul 13, 2022 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 7, 2022 RFCR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 6, 2022 GPRN
PRIORITY ACTION E-MAILED
Jul 6, 2022 GPRA
PRIORITY ACTION WRITTEN
Jul 6, 2022 CPRA
ASSIGNED TO EXAMINER
Jul 5, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 20, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 20, 2022 COAR
APPLICATION FILING RECEIPT MAILED
May 10, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 3, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 21, 2022 SDRC